CRH Medical logo

CRH - CRH Medical Share Price

C$3.32 0.1  3.1%

Last Trade - 10/08/20

Sector
Healthcare
Size
Small Cap
Market Cap £136.2m
Enterprise Value £214.8m
Revenue £89.3m
Position in Universe 492nd / 2678
Bullish
Bearish
Unlock CRH Revenue
Momentum
Relative Strength (%)
1m +5.31%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -43.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
12.0 46.0 78.4 95.0 112.7 120.4 76.2 120.4 +58.6%
-41.1 +100.1 +136.7 +27.0 -64.4 -19.4 +150.6 -79.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, CRH Medical Corp revenues decreased 13% to $25.5M. Net loss increased from $77K to $2.1M. Revenues reflect Anesthesia services decrease of 13% to $23.2M, Product sales decrease of 5% to $2.3M. Higher net loss reflects Corporate expense increase of 39% to $2.2M (expense), (Gain) loss from equity investment decrease from $125K (income) to $16K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CRH Revenue Unlock CRH Revenue

Net Income

CRH Net Income Unlock CRH Revenue

Normalised EPS

CRH Normalised EPS Unlock CRH Revenue

PE Ratio Range

CRH PE Ratio Range Unlock CRH Revenue

Dividend Yield Range

CRH Dividend Yield Range Unlock CRH Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CRH EPS Forecasts Unlock CRH Revenue
Profile Summary

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company is focused on providing gastroenterologists throughout the United States with services and products for the treatment of gastrointestinal diseases. The Company provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. In addition, the Company owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that provides gastrointestinal is a single use, disposable, hemorrhoid banding technology for treating all hemorrhoid grades. The Company distributes the O'Regan System, treatment protocols, operational and marketing expertise as a complete package directly to gastroenterology practices, creating meaningful relationships with the gastroenterologists it serves.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated April 12, 2001
Public Since February 9, 1995
No. of Shareholders: n/a
No. of Employees: 105
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index
Exchange Toronto Stock Exchange
Shares in Issue 71,564,584
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CRH Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CRH
Upcoming Events for CRH
Tuesday 11th August, 2020
Q2 2020 CRH Medical Corp Earnings Call
Frequently Asked Questions for CRH Medical
What is the CRH Medical share price?

As of 10/08/20, shares in CRH Medical are trading at C$3.32, giving the company a market capitalisation of £136.2m. This share price information is delayed by 15 minutes.

How has the CRH Medical share price performed this year?

Shares in CRH Medical are currently trading at C$3.32 and the price has moved by -22.97% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the CRH Medical price has moved by -24.4% over the past year.

What are the analyst and broker recommendations for CRH Medical?

Of the analysts with advisory recommendations for CRH Medical, there are there are currently 2 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for CRH Medical is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will CRH Medical next release its financial results?

CRH Medical is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the CRH Medical dividend yield?

CRH Medical does not currently pay a dividend.

Does CRH Medical pay a dividend?

CRH Medical does not currently pay a dividend.

When does CRH Medical next pay dividends?

CRH Medical does not currently pay a dividend.

How do I buy CRH Medical shares?

To buy shares in CRH Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of CRH Medical?

Shares in CRH Medical are currently trading at C$3.32, giving the company a market capitalisation of £136.2m.

Where are CRH Medical shares listed? Where are CRH Medical shares listed?

Here are the trading details for CRH Medical:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: CRH
What kind of share is CRH Medical?

Based on an overall assessment of its quality, value and momentum, CRH Medical is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a CRH Medical share price forecast 2020?

Shares in CRH Medical are currently priced at C$3.32. At that level they are trading at 18.22% discount to the analyst consensus target price of 0.00.

Analysts covering CRH Medical currently have a consensus Earnings Per Share (EPS) forecast of 0.13 for the next financial year.

How can I tell whether the CRH Medical share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CRH Medical. Over the past six months, the relative strength of its shares against the market has been -36.25%. At the current price of C$3.32, shares in CRH Medical are trading at -9.6% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the CRH Medical PE Ratio?

The CRH Medical PE ratio based on its reported earnings over the past 12 months is 90.76. The shares are currently trading at C$3.32.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of CRH Medical?

CRH Medical's management team is headed by:

Anthony Holler - CHM
Todd Patrick - IND
Ian Webb - LED
Richard Bear - CFO
Bergein Overholt - IND
David Johnson - IND
James Kreger - CEX
Tushar Ramani - CHM
Tom Sanders - VPR
Brian Griffin - IND
Who are the major shareholders of CRH Medical?

Here are the top five shareholders of CRH Medical based on the size of their shareholding:

Nantahala Capital Management, LLC Hedge Fund
Percentage owned: 9.13% (6.53m shares)
Stadium Capital Management, LLC Hedge Fund
Percentage owned: 6.81% (4.87m shares)
Beutel, Goodman & Company Ltd. Investment Advisor
Percentage owned: 6.11% (4.37m shares)
Pacific Ridge Capital Partners, LLC Investment Advisor
Percentage owned: 3.8% (2.72m shares)
Wellington Management Company, LLP Investment Advisor/Hedge Fund
Percentage owned: 2.93% (2.09m shares)
Similar to CRH
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.